| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73514a82d40d7976a333e6e11039ae41 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6884
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6857 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2013-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fde562ad5c75e1b3a0aa2a21e4e5bfde
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32ec85b864920225953146d733483417
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_806f695a6b2beca9c76646258712029f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e4748c0e1aad2657e7cf75e81929e87 |
| publicationDate |
2014-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101384686-B1 |
| titleOfInvention |
Method of predicting responsiveness of lung cancer treatment to egfr targeting agent |
| abstract |
The present invention relates to a method of improving a treatment effect of a patient with acquired tolerance by predicting the responsiveness of a non-small cell lung cancer patient to an agent targeting an epidermal growth factor receptor (EGFR). According to the present invention, the method can predict the responsiveness of the lung cancer patient to a treatment, thereby solving problems of low chances of successful treatment due to tolerance, estimating the prognosis of an anticancer drug, and deciding a therapy plan. [Reference numerals] (AA,CC) Case number; (BB,DD) IHC photo; (CC) Nano C-S-H 0.2% |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101872624-B1 |
| priorityDate |
2013-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |